Pharmakotherapie der enuresis

Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie

Volumn 24, Issue 1, 1996, Pages 18-33

  Von Gontard, A ^a   Lehmkuhl, G ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Desmopressin; Enuresis; Idiopathic urge incontinence; Imipramine; Oxybutynin; Pharmacotherapy; Tricyclic antidepressants

Indexed keywords

ARGIPRESSIN; DESMOPRESSIN; IMIPRAMINE; OXYBUTYNIN; SEDATIVE AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; CARDIOTOXICITY; CHILD; DYSPNEA; ENURESIS; EPISTAXIS; HEADACHE; HUMAN; HYPOTENSION; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TASTE DISORDER; VISUAL IMPAIRMENT; XEROSTOMIA;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; CHILD; DEAMINO ARGININE VASOPRESSIN; ENURESIS; HUMANS; IMIPRAMINE; MANDELIC ACIDS; PARASYMPATHOLYTICS; RENAL AGENTS;

EID: 0030003955     PISSN: 14224917     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Ambrosini, P.J.; Bianchi, M.D.; Rabinovich, H.; Elia, J.: Antidepressant treatments in children and adolescents I. Affective disorders. Journal of the American Academy of Child and Adolescent Psychiatry 32, 1-6, 1993a.
2. Ambrosini, P.J.; Bianchi, M.D.; Rabinovich, H.; Elia, J.: Antidepressant treatments in children and adolescents: II. Anxiety, physical and behavioral disorders. Journal of the American Academy of Child and Adolescent Psychiatry 32, 483-493, 1993b.
3. Bach, D.: Oxybutinin (Dridase) - praktische und klinische Bedeutung. Internistische Praxis 29, 806-808, 1989.
4. Bartels, M.G.; Varley, C.K.; Mitchell, J.; Stamm, S.J.: Pediatric cardiovascular effects of imipramine and desipramine. Journal of the American Academy of Child and Adolescent Psychiatry 30, 100-103, 1991.
5. Beach, P.S.; Beach, R.E.I.; Smith, C.R.: Hyponatremic seizures in a child treated with desmopressin to control enuresis. A rational approach to fluid intake. Clinical Pediatrics 31, 566-569, 1992.
6. Beetz, R.: Funktionelle Aspekte der Enuresis im Kindesalter-Bedeutung für Diagnostik und Therapie. Aktuelle Urologie 24, 241-250, 1993.
7. Biederman, J.; Baldessarini, R.J.; Wright, V.; Knee, K.; Harmatz, J.S.; Goldblatt, A.: A double-blind placebo controlled study of desipramine in the treatment of ADD: II. Serum drug levels and cardiovascular findings. Journal of the American Academy of Child and Adolescent Psychiatry 28, 903-911, 1989.
8. Biederman, J.: Sudden death in children treated with a trycyclic antidepressant. Journal of the American Academy of Child and Adolescent Psychiatry 30, 495-498, 1991.
9. Biederman, J.; Baldessarini, R.J.; Goldblatt, A.; Lapey, K.A.; Doyle, A.; Hesslein, P.S.: A naturalistic study of 24-h electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine. Journal of the American Academy of Child and Adolescent Psychiatry 32, 805-813, 1993.
10. Brook, C.G.D.: The physiology of arginine vasopressin. In: Meadow, S.R. (ed.), Desmopressin in nocturnal enuresis - proceedings of an international symposium. Horus Medical Publications, Canwell, England, 1989, 22-25.
11. Butler, R.J.: Nocturnal Enuresis: Psychological Perspectives. Bristol, Wright, 1987.
12. Dittman, R.W.; Wolter, S.: Primary enuresis nocturna and desmopressin treatment: Do psychological factors affect outcome? European Journal of Child and Adolescent Psychiatry; Zur Veröffentlichung eingereicht, 1995.
13. Djurhuus, J.C.; Norgaard, J.P.; Hjälmas, K.; Wille, S. (eds.): Nocturnal enuresis - a new strategy for treatment against a physiological background. Scandinavian Journal of Urology and Nephrology Suppl. 143, 1992.
14. Elmer, M.; Alm, P.; Kullendorff, C.M.: Innervation of the child urinary bladder. Scandinavian Journal of Urology and Nephrology 20, 267-273, 1986.
15. Evans, J.H.C.: The efficacy of DDAVP in the treatment of nocturnal enuresis in: Meadow, S.R. (ed.) Desmopressin in nocturnal enuresis - proceedings of an international symposium. Horus Medical Publications, Canwell, England, 1989, 29-34.
16. Fergusson, D.M.; Horwood, L.J.; Shannon, F.T.: Factors related to the age of attainment of nocturnal bladder control. Pediatrics 78, 884-890, 1986.
17. Fernandez de Gatta, M.M.; Galindo, P.; Rey, F.; Guitierrez, J.; Tamayo, M.; Garcia, M.J.; Dominguez-Gil, A.: The influence of clinical and pharmacological factors on enuresis treatment with imipramine. British Journal of Clinical Pharmacology 30, 693-698, 1990.
18. Fjellstad-Paulsen, A.; Wille, S.; Harris, A.: Comparison of intranasal and oral desmopressin for nocturnal enuresis. Archives of Disease in Childhood 62, 674-677, 1987.
19. Fjellstad-Paulsen, A.; Höglund, P.; Lundin, S.; Paulsen, O.: Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers. Clinical Endocrinology 38, 177-182, 1993.
20. Foxman, B.; Valdez, B.; Brook, R.H.: Childhood enuresis: prevalence, perceived impact, and prescribed treatment. Pediatrics 77, 482-487, 1986.
21. Fritz, G.K.; Rockney, R.M.; Yeung, A.S.: Plasma levels and efficacy of imipramine treatment of enuresis. Journal of the American Academy of Child and Adolescent Psychiatry 33, 60-64, 1994.
22. Furlanut, M.; Montanari, G.; Benetello, P.; Bonin, P.; Schiaulini, P.; Pellegrino, P.A.: Steady - state serum concentrations of imipramine, its main metabolites and clinical response in primary enuresis. Pharmacological Research 21, 561-566, 1989.
23. de Graaf, M.J.M.: 40 years of being treated for nocturnal enuresis. Lancet 340, 957, 1992.
24. Hellström, A.L.; Hanson, E.; Hansson, S.; Hjälmas, K.; Jodal, U.: Micturition habits and incontinence in 7-year-old Swedish school entrants. European Journal of Pediatrics 149, 434-437, 1990.
25. Hjälmas, K.; Bengtsson, B.: Efficacy, safety and dosing of desmopressin for nocturnal enuresis in Europe. Clinical Pediatrics, special edition, 19-27, 1993.
26. Hogg, R.J.; Husman, D.: The role of family history in predicting response to desmopressin in nocturna e enuresis. Journal of Urology 150, 444-445, 1993.
27. Homsy, Y.L.; Nsouli, I.; Hamburger, B.; Laberge, I.; Schuck, E.: Effects of Oxybutinin on vesico-ureteral reflux in children. Journal of Urology 134, 1168-1171, 1985.
28. Houts, A.C.; Berman, J.S.; Abramson, H.: Effectiveness of psychological and pharmacological treatments for nocturnal enuresis. Journal of Consulting and Clinical Psychology 62, 737-745, 1994.
29. Jonville, A.P.; Dutertre, J.P.; Autret, E., Barbellion, M.: Adverse effects of oxybutinin chloride. Evaluation of the official survey of regional pharmacovigilance centers. Therapy 47, 389-392, 1992.
30. Jorgensen, O.S.; Lober, M.; Christiansen, J.; Gram, L.F.: Plasma concentration and clinical effect in imipramine treatment of childhood enuresis. Clinical Pharmacokinetics 5, 386-393, 1980.
31. Knudsen, U.B.; Rittig, S.; Norgaard, J.P.: Lundemose, J.B.; Pedersen, E.B.; Djurhuus, J.C.: Long-term treatment of nocturnal enuresis with desmopressin - a follow-up study. Urological Research 19, 237-240, 1991.
32. Lovering, J.S.; Tallett, S.E.; McKendry, J.B.: Oxybutinin efficacy in the treatment of primary enuresis. Pediatrics 82, 104-106, 1988.
33. Matthiesen, T.B.; Rittig, S.; Djurhuus, J.C.; Norgaard, J.P.: A dose titration, and an open 6-week efficacy and safety study of desmopressin tablets in the management of nocturnal enuresis. Journal of Urology 151, 460-463, 1994.
34. Mesaros, J.D.: Fluoxetine for primary enuresis (letter). Journal of the American Academy of Child and Adolescent Psychiatry 32, 877-878, 1993.
35. Michele, S.; Sillen, U.; Engel, J.; Hjälmas, R.K.; Rubenson, A.: Evidence for increase in motor activity by vasopressin and desmopressin via central nervous mechanisms. 2. International Children's Continence Symposium, Rom 1993.
36. Miller, K.; Klauber, G.T.: Desmopressin acetate in children with severe primary nocturnal enuresis. Clinical Therapeutics 12, 357-366, 1990.
37. Miller, K.; Goldberg, S.; Atkin, B.: Nocturnal enuresis: experience with long-term use of intranasally administered desmopressin. In: Meadow, S.R. (ed.) Desmopressin in nocturnal enuresis-proceedings of an international symposium. Horus Medical Publications, Canwell, England, 1989, 56-62.
38. Moffat, M.E.K.; Harlos, S.; Kirshen, A.J.;Burd, L.: Desmopressin acetate and nocturnal enuresis: how much do we know? Pediatrics 92, 420-425, 1993.
39. Nissen, G.; Eggers, Ch.; Maitinius, J.: Kinder- und jugend-psychiatrische Pharmakotherapie in Klinik und Praxis. Berlin, Heidelberg: Springer Verlag, 1984.
40. Norgaard, J.P.; Joergensen, J.C.: Pharmacokinetics of DDAVP in treatment of nocturnal enuresis. Journal of Urology 143, 218-000, 1990.
41. Olbing, H.: Idiopathische Dranginkontinenz. Pädiatrische Praxis 35, 413-438, 1989.
42. Olbing, H. (Hrsg.). Enuresis und Harninkontinenz bei Kindern. München, Hans Marseille Verlag, 1993a.
43. Olbing, H.; Norgaard, J.P.; Djurhuus, J.C.: Primäre isolierte Enuresis nocturna. In: Olbing, H. (Hrsg.) Enuresis und Haminkontinenz bei Kindern. München, Hans Marseille Verlag, 1993b; 9-19.
44. Olbing, H.: Streßinkontinenz. In: Olbing, H. (Hrsg.): Enuresis und Harninkontinenz bei Kindern. München: Hans Marseille Verlag, 1993c; 79-82.
45. Olbing, H.: Idiopathische Dranginkontinenz (Detrusorinstabilität); in Olbing, H. (Hrsg.): Enuresis und Harninkontinenz bei Kindern. Hans Marseille Verlag, München, 21-44, 1993d.
46. Persson-Jünemann, Ch.; Seemann, O.; Köhrmann, K.U.; Jünemann, K.P.; Alken, P.: Comparison of urodynamic findings and response to oxybutinin in nocturnal enuresis. European Urology 24, 92-96, 1993.
47. Puri, V.N.: Increased urinary antidiuretic hormone excretion by imipramine. Experimental Clinical Endocrinology 88, 112-114, 1986.
48. Rapoport, J.L.; Mikkelsen, E.J.; Zavadil, A.; Nee, L.; Gruenau, C.; Mendelson, W.; Gillin, C.: Childhood Enuresis II, Psychopathology, trycyclic concentration in plasma, and antidiuretic effect. Archives of General Psychiatry 37, 1146-1152, 1980.
49. Riddle, M.A.; Nelson, J.C.; Kleinman, C.S.; Rasmusson, A.; Leckman, J.F.; King, R.A.; Cohen, D.J.: Sudden death in children receiving Norpramin: a review of three reported cases and commentary. Journal of the American Academy of Child and Adolescent Psychiatry 30, 104-108, 1991.
50. Riddle, M.A.; Geller, B.; Ryan, N.: Another sudden death in a child treated with desipramine. Journal of the American Academy of Child and Adolescent Psychiatry 32, 792-797, 1993.
51. Rittig, S.; Knudsen, U.B.; Norgaard, J.P.; Pedersen, E.B.; Djurhuus, J.C.: Abnormal diural rhythm of plasma vasopressin and urinary output in patients with enuresis. American Journal of Physiology 25, 664-671, 1989a.
52. Rittig, S.; Knudsen, U.B.; Sorensen, S.I.; Djurhuus, J.C.; Norgaard, J.P.: Long-term double-blind cross-overstudy of desmopressin intranasal spray in the management of nocturnal enuresis. In: Meadow, S.R. (ed.) Desmopressin in nocturnal enuresis - Proceedings of an international Symposium. Horus Medical Publications, Canwell, England, 1989b, 43-55.
53. Schlamp, D.; Braun-Scharm, H., Pannenbecker, J.; Freisleder, F.J. Enuresis nocturna und DDAVP: Kritische Überlegungen zur Pathophysiologie und Risiken. Zeitschrift für Kinder- und Jugendpsychiatrie 23, Suppl. 1, 152-153, 1995.
54. Schmitt, B.D.: Efficacy and safety of drugs available for the treatment of enuresis. Drug Investigation 2 (Suppl. 5), 9-16, 1990.
55. Shu, S.; Lu, Y.; Chi, C.: The efficacy of intranasal DDAVP therapy in children with nocturnal enuresis. Chinese Medical Journal 52, 368-371, 1993.
56. Sillen, U.; Rubenson, A.; Hanson, E.: Evidence for a bladder motor inhibition by desmopressin via central transmitter mechanisms. Neurology and Urodynamics 9, 449, 1990.
57. Stegat, H.: Einflußgrößen auf die apparative Verhaltenstherapie der Enuresis. Zeitschrift für Kinder- und Jugendpsychiatrie 19, 38-48, 1991.
58. Stegat, H.: Pharmakobiologische Verfahren zur Behandlung der Enuresis und apparative Verhaltenstherapie. Urologe (A) 31, 106-114, 1992.
59. Stenberg, A.; Läckgren, G.: Treatment with oral Desmopressin in adolescents with primary nocturnal enuresis. Clinical Pediatrics, special edition, 25-27, 1993.
60. Sukhai, R.N.; Mol, J.; Harris, A.S.: Combined therapy of enuresis alarm and desmopressin in the treatment of nocturnal enuresis. European Journal of Pediatrics 148, 465-467, 1989.
61. Terho, P.: Desmopressin in nocturnal enuresis. Journal of Urology 145, 818-820, 1991.
62. Tingelstad, J.B.: The cardiotoxicity of the trycyclics. Journal of the American Academy of Child and Adolescent Psychiatry 30, 845-846, 1991.
63. Thüroff, J.W.; Bunke, B.; Ebner, A., Faber, P.; de Greeter, P.; Hannappel, I.; Heidler, H.; Madersbacher, H.; Melchior, H.; Schäfer, W.; Schwenzer, T.; Stöckle, M.: Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to destrusor hyperactivity: Oxybutinin versus propantheline versus placebo. Journal of Urology 145, 813-817, 1991.
64. Vilhardt, H.: Pharmacology of desmopressin. In: Meadow, S.R. (ed.) Desmopressin in nocturnal enuresis - proceedings of an international symposium. Horus Medical Publications Canwell, England, 1989, 26-28.
65. Vilhardt, H.: Basic pharmacology of desmopressin - a review. Drug Investigation 2 (Suppl. 5), 2-8, 1990.
66. Walsh, B.T.; Giardina, E.-G.; Sloan, R.P.; Greenhill, L.; Goldfein, J.: Effects of desipramine on autonomic control of the heart. Journal of the American Academy of Child and Adolescent Psychiatry 33, 191-197, 1994.
67. Wilens, T.E.; Biederman, J.; Baldessarini, R.J.; Puopolo, P.R.; Flood, J.G.: Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine. Journal of the American Academy of Child and Adolescent Psychiatry 32, 798-804, 1993.
68. Wille, S.: Comparison of desmopressin and enuresis alarm for nocturnal enuresis. Archives of Disease in Childhood 61, 30-33, 1986.
69. Willig, R.P.; Butenandt, O.; Ranke, M.: Ist die Behandlung der primären Enuresis nocturna mit Desmopressin (DDAVP) sinnvoll? Deutsches Ärzteblatt 90, 864-865, 1993.
70. Wood, C.M.; Butler, R.J.; Penney, M.D.; Holland, P.C.: Pulsatile release of arginine vasopressin (AVP) and its effect on response to desmopressin in enuresis. Scandinavian Journal of Urology and Nephrology Suppl. 163, 93-101, 1994.
71. Yaouyanc, G.; Jonville, A.P.; Yaouyanc-Lapalle, H.; Barbier, P.; Duterbre, J.P.; Autret, E.: Seizure with hyponatremia in a child prescribed desmopressin for nocturnal enuresis. Journal of Toxicology and Clinical Toxicology 30, 637-641, 1992.